SGCIA
ELAN icon

Smith Graham & Co Investment Advisors’s Elanco Animal Health ELAN Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$4.81M Buy
322,497
+44,527
+16% +$504K 0.55% 82
2023
Q3 		$3.12M Buy
+277,970
New +$3.23M 0.39% 122

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Smith Graham & Co Investment Advisors's ELAN Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors increased its Elanco Animal Health (ELAN) stake by 16% in Q4 2023, buying an estimated $504K and bringing the position to 322,497 shares worth $4.81M. The position accounts for 0.55% of the portfolio, ranked #82.

Smith Graham & Co Investment Advisors first reported a position in ELAN in Q3 2023 and has held it in 2 quarters since. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • Smith Graham & Co Investment Advisors held 322,497 shares of Elanco Animal Health worth $4.81M as of Q4 2023.
  • Smith Graham & Co Investment Advisors bought 44,527 Elanco Animal Health shares in Q4 2023, an estimated $504K.
  • Elanco Animal Health made up 0.55% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #82 holding.
  • Smith Graham & Co Investment Advisors first reported a position in Elanco Animal Health in Q3 2023 and has held it in 2 quarters since.
  • 355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.